Incident adverse events following therapy for acute promyelocytic leukemia.

about

Incident adverse events following therapy for acute promyelocytic leukemia.

Item

http://www.wikidata.org/entity/Q55412183

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Incident adverse events following therapy for acute promyelocytic leukemia.

@en

Incident adverse events following therapy for acute promyelocytic leukemia.

@nl

type

Item

label

Incident adverse events following therapy for acute promyelocytic leukemia.

@en

Incident adverse events following therapy for acute promyelocytic leukemia.

@nl

prefLabel

Incident adverse events following therapy for acute promyelocytic leukemia.

@en

Incident adverse events following therapy for acute promyelocytic leukemia.

@nl

P1476

Incident adverse events following therapy for acute promyelocytic leukemia.

@en

P2093

Amir T Fathi

http://www.w3.org/2001/XMLSchema#string

Andrew M Brunner

http://www.w3.org/2001/XMLSchema#string

Evan C Chen

http://www.w3.org/2001/XMLSchema#string

Kelly Bridgham

http://www.w3.org/2001/XMLSchema#string

Mahesh K Vidula

http://www.w3.org/2001/XMLSchema#string

Olga Pozdnyakova

http://www.w3.org/2001/XMLSchema#string

Peter Geon Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence.

Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.

Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.

Genome-wide functions of PML-RARα in acute promyelocytic leukaemia

P304

79-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.LRR.2018.05.001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29892554

http://www.w3.org/2001/XMLSchema#string

P932

5993355

http://www.w3.org/2001/XMLSchema#string